Transgene Biotek Ltd to Hold Board Meeting to Approve Q4 FY26 Financial Results
Transgene Biotek Ltd has scheduled a Board of Directors meeting for Friday, May 29, 2026. The meeting aims to review and approve the company's financial performance for the recently concluded quarter and financial year.The primary agenda item for the board is the consideration and approval of the Audited Financial Results of the company. This includes both the Standalone and consolidated financial statements for the fourth quarter and the financial year ended March 31, 2026.
In addition to approving the annual results, the board meeting will also address any other business matters, subject to the permission of the Chair.
Stock Price Movement
As we stand at 09:50, Transgene Biotek Ltd shares are holding steady at ₹3.11, reflecting no change for the day. Throughout the session, the shares have traded within a noticeable range, charting between a low of ₹3.05 and a high of ₹3.24.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.